For research use only. Not for therapeutic Use.
m-PEG4-Boc (Cat.No:I016450) is a polyethylene glycol derivative used in bioconjugation and drug delivery applications. It consists of a methoxy polyethylene glycol (m-PEG) chain with a tert-butyloxycarbonyl (Boc) protecting group. m-PEG4-Boc is commonly employed to modify biomolecules, such as proteins and peptides, to enhance their stability, solubility, and pharmacokinetic properties for therapeutic purposes.
| Catalog Number | I016450 |
| CAS Number | 883554-11-8 |
| Molecular Formula | C₁₄H₂₈O₆ |
| Purity | ≥95% |
| Target | PROTAC |
| IUPAC Name | tert-butyl 3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]propanoate |
| InChI | InChI=1S/C14H28O6/c1-14(2,3)20-13(15)5-6-17-9-10-19-12-11-18-8-7-16-4/h5-12H2,1-4H3 |
| InChIKey | JUINYDFUOXIVCX-UHFFFAOYSA-N |
| SMILES | CC(C)(C)OC(=O)CCOCCOCCOCCOC |
| Reference | [1]. Hervé Bouchard, et al. Peptidic linkers and cryptophycin conjugates, useful in therapy, and their preparation. WO2018206635A1.<br>[2]. Peter Madsen, et al. Protease stabilized, pegylated insulin analogues. WO2009010428A1. |
